Regencell Bioscience Lim...
4.86
0.05 (1.04%)
At close: Jan 14, 2025, 9:00 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY13 FY12 FY11 FY10 FY09 FY07 FY06 FY05 FY04 FY02
Net Income -4.36M -6.06M -7.59M -1.35M -812.37K -390.99K 112.30M 170.40M 153.40M 105.60M 157.70M 144.80M 77.60M 95.50M 72.00M 363.00M 86.00M 82.00M 185.00M 117.00M
Depreciation & Amortization 745.59K 769.69K 604.40K 26.46K 9.52K n/a 254.80M 230.70M 216.80M 212.00M 204.50M 186.20M 226.20M 201.90M 202.00M 183.00M 197.00M 174.00M 158.00M 134.00M
Stock-Based Compensation 449.31K 922.62K 2.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -585.37K -508.94K -1.02M 552.98K 76.28K n/a -37.80M -23.60M -3.90M -40.00M 8.60M -42.20M 8.50M 11.60M -93.00M -2.00M -315.00M 73.10M -36.00M 85.00M
Other Non-Cash Items -248.00K -85.40K -10.73K 52.91K 19.03K n/a 68.00M 65.60M 31.30M 71.60M -34.90M 128.50M -9.30M 64.50M 101.10M -18.80M 61.60M 73.90M n/a 23.00M
Deferred Income Tax n/a 1.42K n/a n/a n/a n/a 600.00K 2.40M -10.90M -6.60M 11.80M -52.40M 7.50M -1.10M -18.00M -4.00M -19.00M 2.00M 26.00M 73.00M
Change in Working Capital -585.37K -508.94K -1.02M 552.98K 76.28K n/a -35.00M -67.40M 35.50M -42.90M -1.50M -70.80M -51.00M 44.10M -92.10M 271.80M -29.60M 50.10M 102.00M 24.00M
Operating Cash Flow -4.00M -4.96M -5.27M -767.31K -726.57K -390.99K 409.90M 410.50M 434.40M 349.10M 346.90M 346.60M 259.40M 410.80M 270.00M 800.00M 304.00M 387.00M 476.00M 373.00M
Capital Expenditures -5.38K -27.39K -780.88K n/a -117.84K n/a -250.40M -214.90M -185.70M -156.80M -112.10M -89.20M -98.40M -108.80M n/a n/a n/a n/a n/a n/a
Acquisitions n/a 970.00 n/a n/a n/a n/a -171.60M n/a n/a n/a -194.40M -89.70M -55.00M n/a -209.00M n/a -34.00M -223.00M n/a n/a
Purchase of Investments -5.00M -10.00M -10.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments 10.25M 10.09M n/a n/a n/a n/a n/a 3.60M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 86.37 -10.00K n/a n/a n/a 11.40M -12.30M 2.40M 287.20M 157.30M 248.50M 70.70M -1.70M -129.00M -47.00M -117.00M -83.00M -181.00M -115.00M
Investing Cash Flow 5.24M 58.98K -10.78M n/a -117.84K n/a -410.60M -223.60M -183.30M 130.40M -149.20M 69.60M -82.70M -110.50M -338.00M -47.00M -151.00M -306.00M -181.00M -115.00M
Debt Repayment n/a n/a n/a 612.06K 988.08K 480.99K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a -228.80M n/a n/a -147.10M -280.90M -109.50M -205.30M -400.00K n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 102.28K 134.91K -267.97K -172.31K n/a n/a -17.00M -160.00M -178.60M -332.40M 83.20M -306.70M -299.50M -142.40M n/a -480.00M -186.00M n/a -281.00M -50.00M
Financial Cash Flow 102.28K 134.91K 22.41M 439.75K 988.08K 480.99K -17.00M -160.00M -178.60M -332.40M 83.20M -306.70M -299.50M -142.40M n/a -480.00M -186.00M n/a -281.00M -50.00M
Net Cash Flow 1.40M -4.85M 6.36M -327.57K 143.67K 90.00K -17.70M 26.90M 72.50M -132.90M 171.90M -143.50M -122.80M 157.90M -68.00M 273.00M -34.00M 81.00M 12.00M 208.00M
Free Cash Flow -4.01M -4.99M -6.05M -767.31K -844.41K -390.99K 159.50M 195.60M 248.70M 192.30M 234.80M 257.40M 161.00M 302.00M 270.00M 800.00M 304.00M 387.00M 476.00M 373.00M